Brief: Miromatrix Announces CEO Jeff Ross To Expand His Role In Research, Development
June 1 (Reuters) - Miromatrix Medical Inc MIRO.O :
* MIROMATRIX ANNOUNCES CEO JEFF ROSS, PH.D. WILL EXPAND HIS
ROLE
BY RESUMING LEADERSHIP OF RESEARCH AND DEVELOPMENT
* MIROMATRIX MEDICAL- REMAIN ON PACE TO SUBMIT RESPONSE TO
FDA'S
CLINICAL HOLD LETTER IN H2 OF 2023 RELATING TO MIROLIVERELAP(TM)
IND APPLICATION
Source text for Eikon: ID:nGNX6pRzmC
Further company coverage: MIRO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Miromatrix Medical
See all newsU.S. STOCKS ON THE MOVE-SeaStar, SJW Group, Pinterest
U.S. STOCKS ON THE MOVE-Crypto, Miromatrix Medical, US banks
U.S. STOCKS ON THE MOVE-JinkoSolar, Reviva, MeiraGTx
U.S. STOCKS ON THE MOVE-McDonald, Coherus BioSciences, Miromatrix,
Brief: Miromatrix To Pay United Therapeutics Termination Fee Of $4 Million In Connection With Termination Of Merger